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1. Introduction 
Reactive oxygen species (ROS), i.e. substances like hydrogen peroxide (H2O2), the 
superoxide anion (O2-) or the highly reactive hydroxyl ion (HO-) as well as reactive nitrogen 
species (RNS) with nitric oxide (NO) as its most important member are ideally suited to 
serve as signaling molecules since they are locally generated, are highly and rapidly 
diffusible and can be neutralized by a bulk of anti-oxidative agents organized in the cellular 
anti-oxidative defense system. So far the signaling pathways regulating organ-specific 
differentiation of stem cells are largely unknown. Differentiation processes of stem cells 
embedded in tissues and organs are tightly regulated by the cellular microenvironment 
which is critically determined by the availability of nutrients and oxygen as well as by the 
balance of ROS and NO generation. Already during early embryogenesis NADPH oxidases 
and NO synthases are expressed in the growing embryo, suggesting that gradients of ROS 
and NO may exist in the developing organs and may be involved in proper functioning of 
commitment programs. During pathophysiological insults, e.g. during hypertension, 
atherosclerosis and cardiac infarction high levels of ROS and NO are generated, thus 
creating an inflammatory microenvironment which on one side contributes to cell damage, 
apoptosis and remodeling, however, on the other side may activate repair processes that 
involve recruitment and differentiation of stem cells of the cardiovascular cell lineage. 
During recent years emerging evidence suggests that ROS and RNS are involved in 
cardiovascular differentiation of embryonic (ES) and adult stem cells. Comparable effects 
may occur during differentiation processes of resident cardiac stem cells. A pivotal role for 
NADPH oxidases and NO synthases in cardiomyogenesis and vasculogenesis of ES cells has 
been recently outlined.  In this chapter the current knowledge on activation, recruitment and 
differentiation of different cardiovascular stem cell populations by ROS and NO and the 
involved signal transduction cascade is reviewed. Furthermore the specific 
microenvironmental requirements for proper stem cell engraftment and maintenance are 
outlined. 
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2. Hypoxia and the anti-oxidative defense of stem cells 
Life on earth requires oxygen for generating energy by metabolic processes. Paradoxically, 
life is on the same time threatened by oxygen, since highly reactive ROS may destruct 
cellular components such as DNA, proteins and lipids by oxidation. Organisms have 
acquired a complex system of antioxidant metabolites and antioxidative enzymes to prevent 
oxidative damage to cellular components. This system comprises of divergent agents such 
as ascorbic acid (Vitamin C), polyphenols, flavonoids, tocopherols, uric acid, glutathione 
and thioredoxins as well as antioxidant enzymes e.g. peroxiredoxins, superoxide dismutase 
and catalase. These antioxidant molecules may be supplemented by the antioxidative 
function of other enzymes that are not directly related to the anti-oxidative defense, like the 
sirtuins which are a phylogenetically conserved NAD+-dependent protein 
deacetylase/ADP-ribosyltransferase family implicated in diverse biological processes. 
Treatment of mouse preimplantation embryos with sirtuin inhibitors resulted in increased 
intracellular ROS levels and decreased blastocyst formation. These effects were 
recapitulated by siRNA-induced knockdown of Sirt3, which is involved in mitochondrial 
energy metabolism, and in Sirt3-/- embryos (Kawamura et al., 2010). Furthermore Prdm16, 
a transcription factor that regulates leukaemogenesis, palatogenesis and brown-fat 
development has been demonstrated to be involved in the maintenance of stem cell function 
by modulating the intracellular redox state. In  stem cells of the haematopoietic and nervous 
systems, Prdm16 deficiency led to increase in ROS levels, depletion of stem cells, increased 
cell death and altered cell-cycle distribution. This could be rescued in the presence of the 
anti-oxidant, N-acetyl-cysteine (Chuikov et al., 2010).  Previously it was assumed that 
antioxidant systems either prevent reactive species from being formed, or remove them 
before they can damage vital components of the cell.  However, research of the last decade 
has unraveled a decisive role of ROS and RNS in cellular signaling where reactive species 
are involved in growth factor, hormone and cytokine function. From this time on it was 
speculated that the function of the antioxidative system is to keep ROS and RNS at an 
optimum homeostatic level that allows the regulation of specific signaling pathways. 
Apparently physiological levels of ROS are necessary to maintain genome stability in ES 
cells and cardiac stem cells. Interestingly antioxidants suppressed DNA damage at low 
concentrations, but potentiated such damage at higher concentrations. High-dose 
antioxidants decreased cellular levels of ATM (ataxia-telangiectasia mutated) and other 
DNA repair enzymes (Li & Marban, 2010). How the redox state inside cells is balanced  is 
yet not known. Current methods of cellular analysis are apparently not sensitive enough to 
discriminate the time and spatial distribution of antioxidants within cells. It may be 
speculated that distinct combinations of antioxidant molecules are spatially distributed 
within cells and/or may be bound to specific cell structures thus allowing the generation of 
gradients of the anti-oxidative defense within cells. These gradients may be further 
diversified by the different anti-oxidative strength of members of the anti-oxidative capacity 
as well as different time durations of the chemical reactions that lead to the neutralization of 
the respective reactive species and termination of the respective signal transduction 
pathway. 
During embryogenesis the early embryo is extremely sensitive towards oxidative stress. 
Extensive research on in vitro fertilization and embryo transfer has demonstrated that 
during embryo culture cell culture media have to be supplemented with distinct cocktails of 
anti-oxidants to avoid serious tissue damage (Agarwal et al., 2008). In the morula state the 
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early embryo passing through the ovary duct as well as the blastocyst prior to implantation 
in the uterus is subjected to severe hypoxia. Since hypoxia via hypoxia-activated 
transcription factors can regulate gene expression it has been speculated that the low oxygen 
pressure present in early embryo may direct the earliest possible differentiation steps 
(Simon & Keith, 2008). Also during early organogenesis, the embryo is in a state of relative 
hypoxia associated with a major decrease in terminal electron transport system activity and 
a marked increase in anaerobic glycolysis (Shepard et al., 2000). Hypoxia can be harmful to 
the embryo which requires the development of protection mechanisms. As recently 
described one of those may involve the adenosine A1 receptor (A1R) since A1R-/- embryos 
were more sensitive towards ischemic stress then normoxic controls and just the heart was 
identified as the site of A1R-mediated embryo protection (Wendler et al., 2007; Wendler et 
al., 2010). The susceptibility of the very early embryo towards oxidative stress may imply 
that also stem cells need either a low oxygen and/or high anti-oxidative status for stem cell 
maintenance. Indeed it has been demonstrated that human ES cells remained in an 
undifferentiated state when cultivated under low oxygen conditions (Ezashi et al., 2005).  
Furthermore it has been shown that bovine blastosysts produced under reduced O2 (< 2% 
O2) tensions displayed significantly more inner cell mass cells displaying pluripotency 
(Harvey et al., 2004). In the adult one of the major sources for stem cells is the bone marrow. 
The bone marrow microenvironment displays a lower oxygen concentration than other 
tissues, and stem cells are localized within the hypoxic regions thus suggesting that hypoxia 
may be crucial for stem cell maintenance.  In hypoxic human ES cells hypoxia inducible 
factor-1┙ (HIF-1┙), a principal mediator of hypoxic adaptations, modulates Wnt/┚-catenin 
signalling by enhancing ┚-catenin activation and expression of the downstream effectors 
LEF-1 and TCF-1. O2 availability, therefore, may have a direct role in stem cell regulation 
through HIF-1┙ modulation of Wnt/┚-catenin signalling (Mazumdar et al., 2010).  In a 
further study it has been recently shown that external addition of anti-oxidant and low 
oxygen tension results in reprogramming of human adipose stromal cells towards a more 
primitive stem cell type (Jee et al., 2010). HIF-2┙ but not HIF-1┙ is a direct upstream 
regulator of the stemness gene Oct-4 since HIF-2┙ was shown to be capable of binding 
hypoxic regulatory elements in the murine Oct-4 promotor (Covello et al., 2006). 
3. ROS generation during embryogenesis 
During later stages of embryogenesis, when the utero-placental circulation is established the 
embryo is more capable to defend against oxidative stress which is due to a stronger anti-
oxidative stress response and at least partially due to the metabolic switch from glycolysis to 
oxidative phosphorylation which occurs at times where the embryonic heart starts to 
contract, thus requesting more energy for heart performance. Despite the sensitivity of the 
early embryo towards oxidative stress few studies demonstrated that ROS at very low 
concentrations are already actively generated during the blastocyste state in rabbits and in 
postimplantation mouse embryos harvested on day 8 of pregnancy; here ROS generation is 
localized to the trophoblast cell layers (Gagioti et al., 1995).  Moreover, placental NADPH 
oxidase-mediated ROS generation occurs in women during early pregnancy and may 
contribute to elevated ROS levels in embryos (Raijmakers et al., 2006). These data suggest 
that very low but physiologically relevant concentrations of ROS may already be involved in 
developmental processes during organogenesis and differentiation of stem cells from the 
inner cell mass. The meaning of ROS during later stages of organ maturation and 
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morphogenesis is not well defined but may at least be involved in neuronal, cardiac and 
vascular growth, where ROS have been shown in several studies to be involved in growth 
factor and cytokine-mediated signaling pathways such as the vascular endothelial growth 
factor/flk-1 (VEGF/flk-1) (Roy et al., 2008),  platelet-derived growth factor BB (PDGF-BB) 
(Lange et al., 2009), cardiotrophin-1 (CT-1) (Sauer et al., 2004) and nerve growth factor 
(NGF)-mediated signaling pathways (Suzukawa et al., 2000). These pathways are associated 
to vasculogenesis, angiogenesis as well as the development of the central and peripheral 
nerve system, where ROS may be involved in the regulation of axon guidance through 
semaphorin 3A (Schwamborn et al., 2004). Furthermore, high levels of ROS have been 
implicated in site-specific cell death in inter-digital regions of the developing limb (Schnabel 
et al., 2006), where peroxidase activity and glutathione peroxidase-4 gene (Gpx4) expression 
were restricted to the non-apoptotic tissue (e.g., digits) of the developing autopod, thus 
suggesting that differential tissue growth may be regulated by redox gradients which are 
determined by distinct expression patterns of anti-oxidant molecules.     
4. Oxidative stress during myocardial infarction – a potential stimulus for 
stem cell activation  
During cardiovascular repair processes embryonic genes are activated, suggesting that 
comparable signaling pathways are involved in embryonic development of the 
cardiovascular system and in cardiac repair during adult live. During hypertension and 
hypertrophic cardiac growth (Akki et al., 2009; Anilkumar et al., 2009) but also in acute 
myocardial infarction (Hori & Nishida, 2009; Di Lisa et al., 2007; Webster et al., 2006), ROS 
are generated in the ischemic myocardium especially after reperfusion. ROS in high 
concentrations directly injure the cell membrane and cause cell death. However, ROS in low 
concentrations also stimulate signal transduction to elaborate inflammatory cytokines, e.g. 
tumour necrosis factor-α (TNF-α), interleukin (IL)-1β and -6, in the ischemic region and 
surrounding myocardium as a host reaction. These inflammatory cytokines regulate cell 
survival and cell death in the chain reaction with ROS (Frangogiannis, 2008). Other 
cytokines like transforming growth factor-β (TGF-β) are upregulated upon inflammation 
(Czarkowska et al., 2004), suggesting that TGF-β signaling may be crucial for repression of 
inflammatory gene synthesis in healing infarcts,  presumably by mediating resolution of the 
inflammatory infiltrate. Furthermore TGF-β may play an important role in modulating 
fibroblast phenotype and gene expression, promoting extracellular matrix deposition in the 
infarct by upregulating collagen and fibronectin synthesis and by decreasing matrix 
degradation through induction of protease inhibitors (Frangogiannis, 2008). TGF-β is also a 
key mediator in the pathogenesis of hypertrophic and dilative ventricular remodeling by 
stimulating cardiomyocyte growth and by inducing interstitial fibrosis (Ellmers et al., 2008). 
Furthermore TGF-β has been demonstrated to enhance cardiomyogenesis of mouse ES cells, 
thus suggesting that stem cell differentiation requires a paracrine pathway within the heart 
(Behfar et al., 2002). 
5. Stem cells within the heart and potential redox-regulated signaling 
pathway involved in stem cell proliferation and specification  
Cardiac repair following myocardial injury is restricted due to the limited proliferative 
potential of adult cardiomyocytes. The ability of mammalian cardiomyocytes to proliferate 
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is lost shortly after birth as cardiomyocytes withdraw from the cell cycle and differentiate. 
However, recent research using integration of carbon-14, generated by nuclear bomb tests 
during the Cold War, into DNA to establish the age of cardiomyocytes in humans revealed 
that cardiomyocytes indeed renew, with a gradual decrease from 1% turning over annually 
at the age of 25 to 0.45% at the age of 75. Fewer than 50% of cardiomyocytes are exchanged 
during a normal life span (Bergmann et al., 2009). In contrast Hsieh et al did not find 
significant cardiac repopulation to occur during normal aging in mice, However, they found 
cardiomyocyte repopulation, albeit modest, by endogenous progenitors following injury, 
e.g. during cardiac infarction (Hsieh et al., 2007), thus suggesting that cardiac repair and 
renewal processes may occur through stem cell-mediated cell replacement. 
The cellular basis for the exchange of cardiomyocytes during human life is not yet known 
but could be comparable to mice due to mobilization of bone marrow-derived stem cells 
(BMSC) and/or the activation of resident stem cells in the heart. Several studies on patients 
have shown that  myocardial infarction results in mobilization of various populations of 
BMSCs which may be involved in cardiac repair processes (Leone et al., 2005; Leone et al., 
2005; Leone et al., 2006; Wojakowski et al., 2009; Wojakowski et al., 2006) Besides BMSCs 
and circulating multipotent progenitor cells (Cesselli et al., 2009) several populations of 
resident cardiac stem cells have been described during recent years. In the early embryo, 
progenitor cells in pharyngeal mesoderm contribute to the rapid growth of the heart tube 
during looping morphogenesis. These progenitor cells constitute the second heart field and 
were first identified in 2001 (Rochais et al., 2009). Side population (SP) cells residing within 
the adult heart and comprising about 1 % of all cells were identified in 2002 by Hierlihy et 
al. who used the Hoechst 33342 dye exclusion procedure which was previously used to 
isolate stem cell populations expressing ATP-binding cassette (ABC) membrane 
transporters, e.g. P-glycoprotein, which confers multidrug resistance in cancer disease 
(Hierlihy et al., 2002). Upon coculture of SP cells from GFP+ mice with adult cardiac cells 
from wild type mice this cell population gained positive α-actinin immunoreactivity, 
suggesting that a cardiac phenotype was attained (Martin et al., 2004). A subpopulation of 
SP cells comprising approximately 10% of the total SP cells expressing the stem cell marker 
Sca-1 was identified by Pfister et al. in 2005. This cell population was negative for the 
endothelial cell marker CD31, expressed Nkx2.5 and GATA-4, but not α-actinin or α-MHC. 
The cells could be differentiated into a more mature cardiac phenotype upon coculture with 
ventricular cardiomyocytes (Pfister et al., 2005).  Upon cardiac infarction the CD31 negative 
cell population in the heart was depleted both within the infarct and non-infarct areas. SP 
pools were subsequently reconstituted to baseline levels within 7 days after myocardial 
infarction, through both proliferation of resident SP cells, as well as through homing of 
BMSCs to specific areas of myocardial injury and immunophenotypic conversion of BMCs 
to adopt a SP phenotype (Mouquet et al., 2005). Besides the SP cell population Sca-1+ c-Kit- 
cells have been reported to be present in the mouse heart (Tallini et al., 2009), and so-called 
cardiospheres were isolated by mild enzymatic digestion of mouse and human heart tissues 
(Messina et al., 2004). A further resident stem cell population within the heart are Isl1+ cells 
which express the islet-1 (Isl1) LIM homeodomain transcription factor (Laugwitz et al., 
2005). Isl1+ cells give rise to cardiomyocyte, endothelial, and smooth muscle lineages in vitro 
and may be involved in embryonic development of the coronary artery tree and for 
coronary artery growth. Previously it was shown that Isl1+ cells with the transcriptional 
signature of Isl1+/Nkx2.5+/flk1+ defines a multipotent cardiovascular progenitor which is 
not only capable to differentiate into cardiac cells but also to smooth muscle and endothelial 
www.intechopen.com
 Embryonic Stem Cells: The Hormonal Regulation of Pluripotency and Embryogenesis 
 
562 
cells which may participate in coronary artery formation (Moretti et al., 2006). During 
embryonic development Isl1 is expressed by progenitor cells of the second heart field that 
gives rise to the formation of the outflow tract, the atria and the right ventricle and is 
required for proliferation, survival, and migration of these progenitors into the forming 
heart (Cai et al., 2003). Isl1 also marks cardiac progenitors found within postnatal hearts of 
rodents and humans (Laugwitz et al., 2005). Recently it has been shown that ┚-catenin 
directly regulates Isl1 expression in cardiovascular progenitors and is required for multiple 
aspects of cardiogenesis (Lin et al., 2007). ┚-catenin is also required upstream of a number of 
genes required for pharyngeal arch, outflow tract, and/or atrial septal morphogenesis, 
including Tbx2, Tbx3, Wnt11, Shh, and Pitx2 (Lin et al., 2007). 
The signaling pathways that regulate differentiation of BMSCs and resident cardiac stem 
cells and/or stimulate proliferation of cardiac progenitor cells are just emerging. Potentially 
inflammation and elevation of ROS levels following cardiac infarction are involved in the 
initiation of signaling pathways that activate quiescent resident cardiac stem cells and 
BMSCs. A beneficial effect of pro-inflammatory signals during bone marrow stem cell 
therapy has been recently outlined (Sun et al., 2009). In the latter study transplanted BMSCs 
increased heart tissue inflammation, and elevated TNF-α, TGF-β and fibroblast growth 
factor-2 (FGF-2) levels which resulted in improved heart function and capillary density in 
the border zone of the myocardial infarct (Sun et al., 2009). Recently it has been shown that 
the redox effector protein-1 (Ref-1) which plays an essential role in DNA repair and redox 
regulation of several transcription factors is involved in the maintenance of cardiac stem 
cells, since Ref-1 inhibition in the presence of exogenous hydrogen peroxide resulted in the 
initiation of cardiac differentiation programs thus suggesting that Ref-1 plays an important 
role in maintaining the redox status of cardiac stem cells and protects them from oxidative 
injury-mediated cell death and differentiation (Gurusamy et al., 2009).  
 Many answers on signaling pathways involved in stem cell activation can be given from 
lessons in cardiac embryology where several signaling pathways that are involved in the 
development of the first heart field and the second heart field have been recently deciphered 
(Rochais et al., 2009). One of the main features of second heart field is the control of cardiac 
progenitor cell proliferation. The latter has been recently shown to be regulated by β-
catenin, the intracellular mediator of the canonical Wnt pathway, which is likewise known 
to be involved in the regulation of several stem cell populations (Reya & Clevers, 2005). Wnt 
signaling displays positive as well as negative effects on early mesoderm commitment and 
cardiac specification depending on the developmental stage of the embryo (Rochais et al., 
2009). In ES cells Wnt signals are required for early mesoderm differentiation (Lin et al., 
2007) whereas during later stages of cardiomyogenesis Wnt signaling restricts cardiac 
differentiation to the lateral splanchnic mesoderm (Tzahor & Lassar, 2001; Nakamura et al., 
2003). Recently it was shown that the Wnt/β-catenin pathway is essential for cardiac 
myogenesis to occur in ES cells, acting at a gastrulation-like stage, and mediating mesoderm 
formation and patterning. Among genes associated temporally with this step was Sox17, 
encoding an endodermal HMG-box transcription factor (Liu et al., 2007).  β-catenin interacts 
with TCF/LEF-1 transcription factors to activate the expression of Wnt target genes. In the 
absence of Wnt signaling, β-catenin function is blocked by a destruction complex consisting 
of Axin, APC and the kinases GSK3ß and CK1α, which targets β-catenin for destruction by 
the proteasome. Binding of Wnt to its receptor Frizzled and LRP leads to inhibition of the 
destruction complex and allows β-catenin signaling. The cytoplasmic protein Dishevelled 
(Dvl) is involved in this process by binding to the redox-sensitive protein nucleoredoxin 
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(NRX) which belongs to the thioredoxin protein family known to be involved in the 
regulation of a variety of ROS mediated signaling pathways (Korswagen, 2006).  ROS are 
presumably involved in a variety of signaling pathways that are crucial for heart 
development. Recently it was shown that ROS can modulate signaling by the Wnt/β-catenin 
pathway (Funato et al., 2006). Oxidative stress inhibits the interaction between NRX and Dvl 
thus stabilizing β-catenin and leading to an increase in the expression of endogenous Wnt 
target genes. Further studies have demonstrated that ROS can also inhibit Wnt/β-catenin 
signaling (Shin et al., 2004) which suggests that a specific time frame and concentration of 
ROS may be necessary for redox-mediated modulation of the Wnt/β-catenin signaling 
pathway. Another important pathway known to be crucial  for cardiac mesoderm 
specification and differentiation is bone morphogenic protein (BMP) pathway. BMP-4 
overexpression promotes a cardiac cell lineage in the cranial mesoderm (Tirosh-Finkel et al., 
2006). BMP-4 is known to be regulated by Wnt/β-catenin and FGF signaling and is involved 
in outflow tract septation which includes smooth muscle and endocardial cushion 
development (Liu et al., 2004). Furthermore BMP-2, another member of the BMP family is 
essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning 
(Ma et al., 2005). Proinflammatory cytokine TNF-α and H2O2 significantly increased 
endothelial expression of BMP-2 but not BMP-4 and induced a proinflammatory endothelial 
phenotype (Csiszar et al., 2006). In further studies the same group demonstrated that BMP-4 
exerts prooxidant, prohypertensive, and proinflammatory effects but only in the systemic 
circulation, whereas pulmonary arteries are protected from these adverse effects of BMP-4 
(Csiszar et al., 2008). BMP-4 by itself may increase ROS generation which has been shown in 
endothelial cells where oscillatory shear stress elevates BMP-4 and induces monocyte 
adhesion by stimulating ROS production from a Nox-1-based NADPH oxidase (Sorescu et 
al., 2004). In malformed embryos from diabetic rats which exert elevated levels of systemic 
ROS sonic hedgehog homolog (Shh) expression was decreased, and BMP-4 was increased, 
thus pointing to a redox sensitive regulation of the Shh/BMP-4 pathway. Recently it has 
been shown that Shh, which is secreted by stem cells in the amphibian intestine, induces 
BMP-4 in subepithelial fibroblasts suggesting that both Shh and BMP-4 are involved in the 
development of the cell-renewable epithelium (Ishizuya-Oka & Hasebe, 2008). 
6. Impact of redox-regulated pro-angiogenic signals during cardiac infarction  
During cardiac insults not only growth factors and cytokines which are involved in the 
proliferation and differentiation of resident cardiac stem cells towards cardiac cells are 
upregulated. The healing of infarction is also grossly dependent on proper 
revascularization. Healing may be dependent on redox-mediated expression/release of pro-
angiogenic growth factors like FGF-2 (Detillieux et al., 2003), VEGF (Wojakowski et al., 2004) 
and PDGF (Zymek et al., 2006) which has been demonstrated to occur after cardiac 
infarction. Pro-angiogenic factors are also released by monocytes and neutrophils (Lambert 
et al., 2008) which are migrating to the area of infarction where they induce formation of 
granulation tissue, containing myofibroblasts and neovessels (Nahrendorf et al., 2007). 
Increasing angiogenic growth factors in the infarcted hearts has therefore been recently used 
for cardioprotection and/or to improve cardiac healing (Lahteenvuo et al., 2009; Zhang et 
al., 2009; Harada et al., 1994; Hsieh et al., 2006b; Hsieh et al., 2006a; House et al., 2003). 
Conversely, inhibition of pro-angiogenic signaling,  e.g.  PDGF-signalling in infarcted hearts 
of mice resulted in impaired maturation of the infarct vasculature, enhanced capillary 
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density, and formation of dilated uncoated vessels. Defective vascular maturation in 
antibody-treated mice was associated with increased and prolonged extravasation of red 
blood cells and monocyte/macrophages (Zymek et al., 2006). VEGF is critical for stem cell-
mediated cardioprotection which was shown in experiments where VEGF was 
downregulated in mesenchymal stem cells by si-RNA approaches. When these cells were 
infused in the coronary circulation the increase in  postischemic myocardial recovery after 
ischemia reperfusion injury was significantly impaired (Markel et al., 2008). Recently suicide 
genes under the control of endothelium (endothelial nitric oxide synthase)-, smooth muscle 
(SM22┙)-, and cardiomyocyte (┙-MHC)-specific promoters, were used to selectively deplete 
the individual cell lineage acquired by transplanted undifferentiated bone marrow-derived 
cells into an acute myocardial infarction model. It was demonstrated that elimination of 
transplanted endothelium-committed or SM22┙-expressing cells, but not cardiac-committed 
cells, induced a significant deterioration of ejection fraction. Moreover, elimination of 
endothelial NO synthase-expressing cells 2 weeks after injection reduced capillary and 
arteriole density (Yoon et al., 2010). The angiogenic factors VEGF, PDGF-BB and FGF-2 are 
all upregulated by exogenous ROS (Sen et al., 2002; Eyries et al., 2004) and exert 
cardioprotective effects under conditions of ischemia-reperfusion injury (Hsieh et al., 2006c; 
Iwai-Kanai et al., 2002).  Bone marrow mesenchymal stem cells by themselves release VEGF 
as a potentially beneficial paracrine response which is enhanced by TGF-α and TNF-α 
(Wang et al., 2008). Furthermore VEGF upregulation has been observed under tissue stress 
conditions associated with ROS generation, e.g. physical exercise (Roy et al., 2008) and 
cardiac infarction, where not only the VEGF gene but also the VEGF receptors flt-1 and flk-1 
were upregulated (Li et al., 1996). Exogenous FGF-2 increased endogenous FGF-2 promoter 
activity and protein levels in ovine pulmonary arterial smooth muscle cells (PASMC). These 
increases in FGF-2 expression were mediated by elevations in superoxide levels via NADPH 
oxidase activation. In addition, FGF-2-mediated increases in FGF-2 expression and 
pulmonary arterial smooth muscle cell (PASMC) proliferation were attenuated by inhibition 
of phosphatidylinositol 3-kinase, Akt, and NADPH oxidase (Black et al., 2008). Comparably 
exogenous ROS increased VEGF and VEGFR expression (Gonzalez-Pacheco et al., 2006; 
Chua et al., 1998), stimulated endothelial cell proliferation and migration (Luczak et al., 
2004) as well as cytoskeletal reorganization (Vepa et al., 1999) and tubular morphogenesis 
(Shono et al., 1996) which all utilize ROS within their signal transduction pathways. 
Addition of PDGF-BB, FGF-2 and VEGF to non-phagocytic cells has been shown to rapidly 
increase ROS generation (Thannickal et al., 2000) which may likewise occur in stem cells 
thus stimulating cardiovascular differentiation.   
7. Redox-regulated pathways involved in mobilization of stem cells from the 
bone marrow 
Stem cells and progenitor cells are mobilized from the bone marrow in response to 
inflammation, tissue injury and cytokines (Aicher et al., 2005). A cytokine playing a 
prominent role in stem cell mobilization, endothelial cell differentiation and vascular repair 
is stromal cell–derived factor-1α  (SDF-1α),  a CXC chemokine known to play a critical role 
in the trafficking of hematopoietic,  lymphopoietic cells as well as stem cell progenitors, and 
in maintaining hematopoietic stem cell niches in bone marrow (Kucia et al., 2004). The high 
SDF-1α content in the bone marrow creates a concentration gradient, which retains 
hematopoietic stem cells within the stem cell niche. Disruption of this SDF-1α gradient 
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results in mobilization of stem cells into the circulation. This degradation occurs after 
upregulation of G-CSF levels during systemic stress or injury. Under these conditions 
elastase is secreted from neutrophils which cleaves membrane-bound SDF-1/CXCR4 
complexes on the surface of bone marrow stem cells in the marrow (Heissig et al., 2002; Jin 
et al., 2008).  SDF-1 is released by stromal cells and binds to its CXCR4 receptor on stem and 
progenitor cells. The signaling cascade following interaction between SDF-1 and CXCR4 
may involve the generation of ROS. This has been recently evidenced in studies on B-
lymphocytes where ROS were involved in CXCR4-induced Akt activation (Lee et al., 2007). 
If high concentration gradients of circulating SDF-1 exist, CXCR4-positive cells are leaving 
the bone marrow to be directed to sites of tissue injury. During tissue damage, ischemia and 
inflammation plasma and tissue levels of SDF-1α are upregulated (Schober, 2008).  
Consequently SDF-1α expression is significantly upregulated in experimental rat and mouse 
models of infarction (Pillarisetti & Gupta, 2001), and in plasma and cardiac tissue of patients 
with myocardial infarction (Yamani et al., 2005).  Furthermore, SDF-1α expression has been 
shown to increase under hypoxic conditions (Ceradini et al., 2004), and thus may serve to 
attract stem cells to sites of tissue injury and ischemia. Recently it has been shown that 
expression of SDF-1α on circulating platelets is increased in patients with acute coronary 
syndrome and correlates with the number of CD34+ progenitor cells (Stellos et al., 2009). 
Expression of SDF-1α appears to be correlated to the expression of eNOS in the heart since 
eNOS -/- mice displayed reduced SDF-1α levels in isolated cardiomyocytes. eNOS in the 
host myocardium promoted mesenchymal stem cell migration to the ischemic myocardium 
and improved cardiac function through cGMP-dependent increases in SDF-1α expression 
(Li et al., 2009). The local inflammatory response implying adhesion molecule expression 
and eNOS-dependent signaling was required for SDF-1α-induced adhesion of c-kit+ cells to 
the vascular endothelium (Kaminski et al., 2008). Furthermore, oxidative stress from lactate 
metabolism by circulating stem/progenitor cells accelerated further stem cell recruitment 
and differentiation through thioredoxin-1 (Trx1)-mediated elevations in HIF-1 levels and the 
subsequent synthesis of HIF-1-dependent growth factors including VEGF and SDF-1α 
(Milovanova et al., 2008). Taken together these data suggest a model whereby, in response 
to tissue injury and inflammation, stem cells within the bone marrow are expanded and 
primed through G-CSF which then results in mobilization of stem cells via degradation of 
SDF-1α in the marrow and recruitment of the stem cells to sites of elevated SDF-1α levels 
within the injured, inflamed or ischemic tissues. Mobilization is then terminated when the 
increased SDF-1α gradient in the marrow is re-established and retains newly formed or non-
mobilized stem cells as a reserve for future emergency signals (Mays et al., 2007). 
Interestingly G-CSF stimulation induced ROS generation in bone marrow neutrophils 
correlating with activation of Lyn, PI3-kinase and Akt, whereas the anti-oxidant N-acetyl 
cysteine diminished G-CSF-induced ROS production and cell proliferation (Zhu et al., 2006). 
Further research on the priming function of G-CSF on ROS generation by neutrophils 
revealed that mitogen-activated protein kinase (MAPK) pathways are involved in 
phosphorylation of Ser345 of p47phox, a cytosolic component of NADPH oxidase in human 
neutrophils (Dang et al., 2006).  Previously it was shown that several hematopoietic growth 
factors including G-CSF signal through the formation of ROS (Sattler et al., 1999) which has 
been associated to a stimulation of cell proliferation of hematopoetic stem cells upon 
treatment with G-CSF (Pyatt et al., 1996). Furthermore the blood oxidative status was found 
to be significantly increased in healthy hematopoetic stem cell donors receiving G-CSF, 
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which indicated that during stem cell mobilization a transient inflammatory status is 
generated (Cella et al., 2006) which may facilitate further stem cell mobilization. ROS 
mediated stem cell mobilization and recruitment may be used in therapeutic angiogenesis 
approaches. In this respect hyperbaric oxygen has been shown to stimulate recruitment and 
differentiation of circulating stem/progenitor cells in subcutaneous Matrigel which was 
inhibited by antagonists of NADPH oxidase and free radical scavengers (Milovanova et al., 
2009).  
Mostly ROS elicited upon growth factor and cytokine signaling are only acting within a 
narrow time window. Recently the interesting concept of the redox window of coronary 
collateral growth was formulated. This concept suggests that the redox window constitutes 
a range in the redox state of cells, which not only is permissive for the actions of growth 
factors but amplifies their actions. Initial changes in cellular redox are arising from  different 
events, e.g. from the oxidative burst during reperfusion following ischemia, to recruitment 
of various types of inflammatory cells capable of producing ROS. Any event that upsets the 
normal redox equilibrium is capable of amplifying growth. However, extremes of the redox 
window, oxidative and reductive stresses, are associated with diminished growth factor 
signaling and reduced activation of redox-dependent kinases (Yun et al., 2009).  Previously 
the same group had demonstrated that ROS are involved in human coronary artery 
endothelial cell (HCAEC) tube formation, coronary collateral growth in vivo, and signaling 
(p38 MAP kinase) by which ROS may stimulate vascular growth (Yun et al., 2009).  
8. ROS and NO generation in bone marrow-derived stem cells 
Besides the role of ROS and NO generated during states of tissue inflammation, ischemia 
and injury, stem cells per se are generating ROS as well as NO which may be involved in 
proliferation and differentiation processes.  ROS and NO generation in stem cells could 
occur in response to transient changes in systemic redox balance and could initiate a 
feedforward cycle of ROS/NO generation and elaboration of a balanced anti-oxidative 
response system that may be the basis of stem cell proliferation, migration and 
differentiation. An increasing number of studies reported on the crucial role of ROS/NO on 
mesenchymal stem cell differentiation. It was shown that neuronal differentiation of 
mesenchymal stem cells involved upregulation of NADPH oxidase and increased ROS 
generation (Wang et al., 2007). Furthermore physical shockwave treatment was shown to 
increase osteogenic activity of human umbilical cord blood (HUCB) mesenchymal 
progenitor cells through superoxide-mediated TGF-β1 induction (Wang et al., 2004). ROS 
generation through the activity of the Nox-2 and Nox-4 isoform of NADPH oxidase has 
been demonstrated in human CD34+ cells which may contribute to the activation of 
intracellular signaling pathways leading to mitochondriogenesis, cell survival, and 
differentiation in hematopoietic stem cells (Piccoli et al., 2007a). In the latter study the 
authors suggested that the coordinated activity of the Nox isoforms in hematopoietic stem 
cells functions as environmental oxygen sensor and generates low level of ROS, which likely 
serve as second messengers. The pro-oxidant setting, entering into play when hematopoietic 
stem and progenitor cells leave the hypoxic bone marrow niche, would enable them to be 
more responsive to proliferative/differentiative stimuli. Moreover it is suggested that 
enhanced ROS elicit mitochondrial "differentiation" in a pre-commitment phase needed to 
match the bioenergetic request in the oncoming proliferation/differentiation process (Piccoli 
et al., 2007b). Mesenchymal stem cells from the bone marrow have been shown to express 
www.intechopen.com
Impact of Reactive Oxygen and Reactive Nitrogen Species  
for Stem Cell Mobilization, Function and Cardiovascular Differentiation   
 
567 
iNOS (Sato et al., 2007) as well as eNOS (Klinz et al., 2005). Recently it was shown that 
hematopoietic stem cell development is dependent on blood flow and and is closely 
associated to NO generation since intrauterine NOS inhibition or embryonic eNOS 
deficiency resulted in a reduction of hematopoietic clusters and transplantable murine 
hematopoietic stem cells (North et al., 2009).  Generation of NO by eNOS has been reported 
in mouse endothelial progenitor cells (EPCs) and was utilized to identify the EPC 
population (Loomans et al., 2006). Administration of Angiotensin II (Ang II) significantly 
promoted NO release, inhibited EPC apoptosis and enhanced EPC adhesion potential (Yin 
et al., 2008). In a recent study it was shown that two NO agents (SNAP and DEA/NO), able 
to activate both cGMP-dependent and -independent pathways, were increasing the 
cardiomyogenic potential of bone marrow-derived mesenchymal stem cells and adipose 
tissue-derived stem cells (ADSCs) (Rebelatto et al., 2009). Furthermore it was recently shown 
that the nitric oxide-soluble guanylyl cyclase pathway is involved in the oxytocin-mediated 
differentiation of porcine bone marrow stem cells into cardiomyocytes (Ybarra et al., 2010).  
9. ROS and NO in cardiovascular differentiation of ES cells 
Most evidence about the role of NO and ROS in cardiovascular differentiation has been 
obtained in mouse ES cells. It was shown that undifferentiated self-renewing stem cells are 
devoid of endogenous ROS generation and expression of NADPH oxidase. Undifferentiated 
ES cells were demonstrated to be equipped with highly efficient mechanisms to defend 
themselves against various stresses and to prevent or repair DNA damage. One of these 
mechanisms is high activity of a verapamil-sensitive multidrug efflux pump. During the 
differentiation process anti-oxidative genes are downregulated which should result in 
increased ROS generation (Saretzki et al., 2004). Consequently, during the differentiation 
process the gp91-phox homologues Nox-1, Nox-2 and Nox-4 are upregulated in a distinct 
time frame, starting with Nox-1 and followed by Nox-4 (Buggisch et al., 2007), whereas Nox-
2 is closely correlated to the differentiation of phagocytic cells from ES cells which occurs 
subsequent to cardiovascular differentiation (Hannig et al., 2010). During the early stages of 
ES cell differentiation, i.e. between day 4 and day 10 of cell culture ROS generation is 
elevated and downregulated during later stages. The stages of active ROS generation are 
just those where cardiovascular differentiation occurs, i.e. between day 4 and day 9 of cell 
culture. Any approaches to increase intracellular ROS, e.g. by addition of nanomolar 
concentrations of H2O2 to differentiating embryoid bodies (Buggisch et al., 2007; Sauer et al., 
1999; Sauer et al., 2000), treatment with direct current electrical fields (Sauer et al., 2005; 
Sauer et al., 1999; Serena et al., 2009), application of mechanical strain (Schmelter et al., 
2006), treatment with cardiotrophin-1 (CT-1) (Sauer et al., 2004), PDGF-BB (Lange et al., 
2009) or peroxisome proliferator-activated receptor α (PPARα) (Sharifpanah et al., 2008) 
resulted in prominent stimulation of cardiovascular differentiation of ES cells.  Interestingly 
elevation of intracellular ROS by exogenous stimulators resulted in upregulation of Nox-1 
and Nox-4 thus initiating a feed-forward stimulation of prolonged ROS generation 
(Schmelter et al., 2006; Buggisch et al., 2007). Consequently, si-RNA inactivation of Nox-4 
resulted in complete inhibition of embryonic stem cell-derived cardiomyogenesis (Li et al., 
2006). Stimulation of ROS generation by different means resulted in activation of the MAPK 
pathways ERK1,2, p38 and JNK. Furthermore stimulation of embryoid bodies by ROS 
resulted in activation of the cardiogenic transcription factors BMP-10, MEF2C, GATA-4, 
DTEF-1 and Nkx-2.5 (Buggisch et al., 2007). Interestingly vasculogenesis required activation 
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of ERK1,2 and JNK whereas p38 activation was dispensable. Cardiomyogenesis, however, 
required the activation of all three pathways since pharmacological inhibition of either 
pathway abolished cardiac cell differentiation (Schmelter et al., 2006). Recently it was 
demonstrated that also smooth muscle differentiation from ES cells is under the control of 
Nox-4. Overexpression of Nox-4 specifically resulted in increased smooth muscle cell 
marker production, whereas knockdown of Nox-4 induced a decrease. Furthermore, smooth 
muscle cell-specific transcription factors, including serum response factor (SRF) and 
myocardin were activated by Nox4 gene expression (Xiao et al., 2009).  When 
cardiomyogenesis was stimulated with CT-1, additionally activation of NF-κB and the 
JAK/STAT signaling pathway in a redox-sensitive manner was observed (Sauer et al., 2004). 
CT-1 has been previously shown to exert cardioprotective effects which may be related to 
the activation of anti-apoptotic signaling pathways (Calabro et al., 2009). CT-1 is expressed 
in post-myocardial infarct heart, and may play an important role in infarct scar formation 
and ongoing remodeling of the scar (Freed et al., 2003). Furthermore, CT-1 is a cytokine that 
induces hypertrophy and has been shown to be increased in hypertensive patients (Lopez et 
al., 2009). An additional role of CT-1 may involve the activation and differentiation of 
resident cardiac stem cells. In this respect is has been recently shown that CT-1 signaling 
through glycoprotein 130 (gp130) regulates the endothelial differentiation of cardiac stem 
cells (Mohri et al., 2009). Recently CT-1 in combination of 5-azacytidine which is an inhibitor 
of DNA methylation was shown to induce cardiac gene expression in mesenchymal stem 
cells (Xinyun et al., 2009).  In human ES cells telomere maintenance, oxidative stress 
generation, and genes involved in antioxidant defense and DNA repair were investigated 
during spontaneous differentiation of two human embryonic stem cell lines. Telomerase 
activity was quickly downregulated during differentiation, probably due to deacetylation of 
histones H3 and H4 at the hTERT promoter and deacetylation of histone H3 at hTR 
promoter. Telomere length decreased accordingly. Mitochondrial superoxide production 
and cellular levels of ROS increased as result of stimulated mitochondrial biogenesis. The 
expression of major antioxidant genes was downregulated despite this increased oxidative 
stress. DNA damage levels increased during differentiation, whereas expression of genes 
involved in different types of DNA repair decreased (Saretzki et al., 2008). Besides the 
evident role of ROS for cardiovascular differentiation a prominent involvement of NO in 
cardiomyogenesis of ES cells has been evidenced. In murine undifferentiated ES cells, NOS-
1, NOS-3, and sGCβ(1) were detected while NOS-2, sGCα(1), and PKG were very low or 
undetectable. When ES cells were subjected to differentiation, NOS-1 abruptly decreased 
within one day, NOS-2 mRNA became detectable after several days, and NOS-3 increased 
after 7-10 days (Mujoo et al., 2006). Components of NO signaling were likewise expressed in 
human ES cells (Mujoo et al., 2006). Nkx2.5 and myosin light chain (MLC2) mRNA 
expression was increased on exposure of mouse and human ES cells to NO donors and a 
decrease in mRNA expression of both cardiac-specific genes was observed with nonspecific 
NOS inhibitor (Mujoo et al., 2008). Recently it was shown that NO acts as a repressor of the 
stemness gene Nanog in mouse and human ES cells. The suppressive action of NO on Nanog 
gene depended on the activation of p53 repressor protein by covalent modifications, such as 
pSer15, pSer315, pSer392 and acetyl Lys 379. NO-induced repression of Nanog was also 
associated with binding of trimethylated histone H3 and pSer315 p53 to its promoter region 
(Mora-Castilla et al., 2010). In several studies it was reported that NO is acting as signaling 
molecule during  cardiomyogenesis of ES cells (Mujoo et al., 2008; Kanno et al., 2004; Bloch 
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et al., 1999). Furthermore NO donors stimulated vasculogenesis of ES cells (Milosevic et al., 
2010). Studies on NO generating agents revealed that sGC activators alone exhibited an 
increase in mRNA expression of cardiac genes (MLC2 and Nkx2.5). Robust inductions of 
mRNA and protein expression of marker genes were observed when NO donors and sGC 
activators were combined. Measurement of NO metabolites demonstrated an increase in the 
nitrite levels in the conditioned media and cell lysates on exposure of cells to the different 
concentrations of NO donors. cGMP analysis in undifferentiated stem cells revealed a lack 
of stimulation with NO donors. Differentiated cells however, acquired the ability to be 
stimulated by NO donors (Mujoo et al., 2008).  Generation of NO is apparently also the 
mediator of cardiomyogenesis of mouse ES cells achieved with the hormone oxytocin  
(Muller et al., 2008) and arginine vasopressin (Gassanov et al., 2007). Hence these data 
suggest that the interplay of ROS and NO is required to direct undifferentiated ES cells into 
the cardiovascular cell lineage.  
10. Conclusions 
Emerging evidence of recent years outlines a decisive role of ROS and RNS in the initiation 
of differentiation programs of stem cells. How this can be achieved is currently difficult to 
investigate due to technical limitations of in vivo detection of short lived radical species and 
subcellular analysis of the distribution of diffusible intracellular anti-oxidants. More than 20 
years ago the free radical theory of development was established by Allen and Balin (Allen 
& Balin, 1989). According to this theory metabolic gradients exist in developing organisms 
and are believed to influence development. Metabolically generated oxidants that are 
counteracted by the antioxidative defense may be one decisive factor that directs the 
initiation of certain developmental events (Allen & Balin, 1989).  The literature reviewed in 
the current article outlines that ROS as well as RNS are involved in stem cell mobilization, 
function and differentiation in a very complex way. To understand how this can function in 
a tissue where many different cell types exist in close proximity remains to be unraveled. 
Barriers of antioxidants have to be postulated that hinder the diffusibility of oxidants in one 
and pave their way in other cellular locations thus achieving distinct redox 
microenvironments and differentiation patterns. The prooxidant role of NO is often 
attributed to RNS intermediates rather than NO itself. NO may react with superoxide which 
– in contrast to H2O2 – is not diffusible across cell membranes. The resulting peroxynitrite 
(ONOO-) can diffuse freely within and out of the cell, and react with lipids, proteins and 
DNA. The balance between NO and superoxide may help to define the prooxidant action of 
NO versus ROS in biological tissues. This interplay may discriminate between pathways 
resulting in oxidative stress and induction of apoptotic pathway versus signaling cascades 
resulting in stem cell maintenance and/or stem cell differentiation.   
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